TrueBlue, Inc. (NYSE:TBI) is scheduled to issue its quarterly earnings data after the market closes on Monday, July 31st. Analysts expect the company to announce earnings of $0.42 per share for the quarter. TrueBlue has set its Q2 guidance at $0.38-0.43 EPS.

TrueBlue (NYSE:TBI) last issued its quarterly earnings data on Monday, May 1st. The business services provider reported $0.21 EPS for the quarter, beating the consensus estimate of $0.12 by $0.09. The company had revenue of $568.24 million during the quarter, compared to analysts’ expectations of $569.85 million. TrueBlue had a negative net margin of 0.66% and a positive return on equity of 16.30%. TrueBlue’s revenue for the quarter was down 12.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.27 earnings per share. On average, analysts expect TrueBlue to post $1.86 EPS for the current fiscal year and $2.04 EPS for the next fiscal year.

TrueBlue, Inc. (NYSE TBI) opened at 26.75 on Monday. TrueBlue, Inc. has a 52 week low of $16.50 and a 52 week high of $28.70. The company’s 50-day moving average is $26.81 and its 200 day moving average is $26.16. The stock’s market cap is $1.11 billion.

In other TrueBlue news, EVP James E. Defebaugh sold 5,000 shares of the stock in a transaction that occurred on Monday, May 8th. The shares were sold at an average price of $27.00, for a total transaction of $135,000.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Derrek Lane Gafford sold 20,000 shares of the stock in a transaction that occurred on Monday, June 5th. The shares were sold at an average price of $27.75, for a total transaction of $555,000.00. Following the sale, the chief financial officer now directly owns 91,859 shares of the company’s stock, valued at $2,549,087.25. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 90,000 shares of company stock valued at $2,479,200. Insiders own 2.00% of the company’s stock.

TBI has been the topic of a number of recent analyst reports. BMO Capital Markets restated a “sell” rating and set a $20.00 target price on shares of TrueBlue in a research note on Wednesday, April 5th. Zacks Investment Research upgraded shares of TrueBlue from a “hold” rating to a “buy” rating and set a $29.00 target price on the stock in a research note on Wednesday, April 12th. Four equities research analysts have rated the stock with a hold rating, The stock currently has an average rating of “Hold” and a consensus price target of $22.50.

TRADEMARK VIOLATION NOTICE: This piece of content was published by American Banking News and is owned by of American Banking News. If you are viewing this piece of content on another site, it was stolen and republished in violation of U.S. and international copyright legislation. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/07/24/trueblue-inc-tbi-scheduled-to-post-quarterly-earnings-on-monday.html.

About TrueBlue

TrueBlue, Inc is a provider of specialized workforce solutions. The Company is engaged in providing staffing, on-site workforce management and recruitment process outsourcing services. The Company operates through three segments: PeopleReady, PeopleManagement and PeopleScout. Its PeopleReady segment provides blue-collar contingent staffing through the PeopleReady service line.

Earnings History for TrueBlue (NYSE:TBI)

Receive News & Ratings for TrueBlue Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TrueBlue Inc. and related companies with MarketBeat.com's FREE daily email newsletter.